2026 Guidelines on Differentiated Service Delivery for Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis in the Prevention of HIV in the Philippines
2026 Dissemination of the Gender-based Violence, Sexual Exploitation, Abuse, and Harassment (GBV SEAH) Action Plan for the Philippines: Health System Resilience Project (PH-HSRP) (DC 2026-0168)
2026 Use of the One HIV, AIDS, and STI Information System (OHASIS) for Reporting Sexually-Transmitted Infections (STIs) and Viral Hepatitis (VH) (DC 2026-0179)
2026 Interim Guidelines on Maintaining Continuity of Antiretroviral Therapy (ART) Amid Temporary Supply Constraints of Tenofovir/Lamivudine/Dolutegravir (TLD) 300/300/50mg (DC 2026-0372)
2026 Dissemination of the National, Regional, and City-Level People Living with Human Immunodeficiency Virus (PLHIV) Estimates for CY 2026–2030 (DC 2026-0393)
2026 Strengthening Condom Access and Distribution as Part of HIV and AIDS Combination Prevention (DC 2026-0532)
2025 Dissemination of the DOH Adjusted GAD Plan and Budget (GPB) Based on the FY 2025 General Appropriations Act (GAA) (DC 2025-0500)
2025 National Policy Framework on Community-Based Mental Health (AO 2025-0028)
2025 Guidelines on the Establishment and Certification of HIV Treatment Hubs in the Philippines
2025 Guidelines in Availing Compassionate Special Permit for the Restricted Use of Covered Pharmaceutical Products and Medical Devices for Human Use
2025 Updated Directory DOH-Licensed Certified Rapid HIV Diagnostic Algorithm (rHIVda) Confirmatory Laboratories in the Philippines as of June 30, 2025 (DC 2025-0307)
2025 Reiteration of the Protocols for Prevention, Detection, and Management of Mpox (DC 2025-0252)
2025 Amendment to the 2022 Guidelines on Differentiated Treatment for PLHIV and Prophylaxis for HIV-Exposed Infants
2025 Optimization of Point-of-Care Nucleic Acid Amplification Test Machines for HIV and TB Testing (DM 2025-0231)
2024 HIV Pre-Exposure Prophylaxis (PrEP) Programmatic Targets (2024–2026) (DC 2024-0507)
2024 rHIVda sites
2024 Reiteration of the Guidelines on the Full Transition to Dolutegravir (DTG)-Based Regimens from Efavirenz-Based Regimens by January 2025 (DC 2024-0340)
2024 Guidance on the Use of TB Preventive Treatment (TPT) Regimens among People Living with HIV (PLHIV)
2023 Interim Guidelines in the Regulation of Confirmatory Rapid HIV Diagnostic Algorithm Clinical Laboratory (CrCL) (DC 2023-0291)
2022 Guidelines in the Implementation of Differentiated HIV Testing
Services
2022 Guidelines on Differentiated Treatment for People Living with Human Immunodeficiency Virus (PLHIV) and Prophylaxis for HIV-Exposed Infants
2022 Guidelines on Tuberculosis – Human Immunodeficiency Virus (TB-HIV) Services Integration for Universal Health Care (UHC) Implementation (AO 2022-0010)
2022 Oral PrEP (Emtricitabine 200 mg FDC + Tenofovir Disoproxil Fumarate 300 mg) in the Philippine National Formulary (PNF) (DC 2022-0044)
2021 Inclusion of Tenofovir/Lamivudine/Dolutegravir (TLD) in the Philippine National Formulary (PNF) (DC 2021-0400)
2021 Philhealth Outpatient HIV/AIDS Treatment Package (Revision 2)
2021 Interim Guidelines on Pre-Exposure Prophylaxis (PrEP) for the Prevention of HIV Infection in the Philippines
2021 Interim Guidelines on the use of OHASIS as the reporting platform of HIV, STI, Hepatitis in the Philippines
2021 Implementing Guidelines for Priority Group A3 and Further Clarification of the National Deployment and Vaccination Plan for COVID-19 Vaccines
2021 National Policy and Strategic Framework on the Men’s Health Program (AO 2021-0025)
2021 Memorandum: Conduct of Online Training on HIV Counseling and Testing
2020 Interim Guidelines on the Management of PLHIV and Protocol on Protection Against HIV Transmission During Medical, Surgical and other Related Procedures
2020 Adoption of PSMID Opportunistic Infections Clinical Practice Guidelines
2020 Updated List of Health Facilities with rHIVda Service as of July 2020
2020 Interim Guidelines on Subsidizing Medical Expenses Incurred by Indigent and Financially Incapacitated PLHIV in DOH Hubs
2020 Interim Guidelines on the Continuity of HIV and STI Services in the Midst of Varying Community Quarantine Systems
2020 Interim Guidelines on Community Based Screening
2019 Philippine HIV Stigma Index
2019 Guidelines in the HMO Underwriting of Applicants with Actual, Perceived, or Suspected HIV Status
2019 Guidelines on Implementing rHIVda
Republic Act 11166 (The New HIV Law)
RA 11166 Implementing Rules and Regulations
2018 ART Guidelines
2017 Treatment of Chronic Hepatitis C among PLHIVs
2017 Testing Guidelines
2017 Management of the HIV-infected Healthcare worker
2016 Enhancing Linkage to Care
2016 Opportunistic Infections in HIV
2016 Updated TB Guidelines
2014 Revised Policies and Guidelines in the Collaborative Approach of TB and HIV Prevention and Control
2010 Immunization for PLHIV
2000 Integration of HIV/AIDS Education in the Tertiary Education Curriculum
Like this:
Like Loading...
